GLP-1 Safety Monitoring: What Your Doctor Should Be Checking

GLP-1 medications are safe and effective when properly monitored. Here's what a responsible provider should be tracking during your treatment.

Before Starting: Baseline Assessments

• BMI and weight: Eligibility requires BMI ≥30 (or ≥27 with comorbidities)
• HbA1c and fasting glucose: Screen for diabetes/prediabetes and establish baseline
• Thyroid function: Personal or family history of medullary thyroid carcinoma or MEN2 is a contraindication
• Kidney and liver function: Baseline metabolic panel
• Gallbladder history: GLP-1s increase gallstone risk; prior gallbladder disease requires extra monitoring
• Current medications: Drug interaction screening, especially for insulin, sulfonylureas, and oral medications affected by delayed gastric emptying

During Treatment: Ongoing Monitoring

Check	Frequency	Why
Weight and BMI	Monthly initially, then quarterly	Track efficacy, adjust dosing
Blood pressure	Each visit	GLP-1s typically lower BP
GI symptoms	Each visit	Nausea/vomiting management
Renal function	Quarterly if risk factors	Dehydration from GI effects
HbA1c	Every 3-6 months	Monitor glycemic improvement
Lipid panel	Every 6-12 months	Track cardiovascular benefit

Red Flags During Treatment

Trusted Providers with Medical Oversight

The Bottom Line

Proper monitoring makes GLP-1 treatment safer and more effective. Any provider that prescribes without baseline labs, ongoing check-ins, and clear emergency protocols isn't meeting the standard of care. Good monitoring isn't bureaucracy — it's how side effects get caught early and dosing gets optimized for your body.